BrainsWay Ltd. Company

Brainsway's patented breakthrough technology launches a new era in brain disorder treatment.

Last Funding Type: Post-IPO Equity
Funding Status: IPO
Headquarters: Jerusalem, Yerushalayim, Israel
Founded Date: 2003-01-01
Last Funding Date: 2021-02-23
Total Funding: 65495696.0
Estimated Revenue: $1M to $10M
Investors Number: 4.0
Industry: Neurodegenerative disease diagnosis and treatment